BCL6

Summary

Gene Symbol: BCL6
Description: B-cell CLL/lymphoma 6
Alias: BCL5, BCL6A, LAZ3, ZBTB27, ZNF51, B-cell lymphoma 5 protein, B-cell lymphoma 6 protein, B-cell lymphoma 6 protein transcript, BCL-5, BCL-6, cys-his2 zinc finger transcription factor, lymphoma-associated zinc finger gene on chromosome 3, protein LAZ-3, zinc finger and BTB domain-containing protein 27, zinc finger protein 51, zinc finger transcription factor BCL6S
Species: human

Top Publications

  1. ncbi PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells
    Fang Wei
    Department of Animal Biology and Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Mol Cell Biol 29:4612-22. 2009
  2. ncbi BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells
    Huifeng Niu
    Institute for Cancer Genetics, Columbia University, 1150 St Nicholas Ave, New York, NY 10032, USA
    J Exp Med 198:211-21. 2003
  3. ncbi Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein
    G David
    Unite de Recombinaison et Expression Genetique, INSERM U163, Institut Pasteur, Paris, France
    Oncogene 16:2549-56. 1998
  4. ncbi Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas
    B W Baron
    Department of Pathology, University of Chicago, IL 60637
    Proc Natl Acad Sci U S A 90:5262-6. 1993
  5. ncbi Control of inflammation, cytokine expression, and germinal center formation by BCL-6
    A L Dent
    Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Science 276:589-92. 1997
  6. ncbi A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas
    Leandro C Cerchietti
    Division of Hematology and Oncology, Weill Cornell Medical College of Cornell University, New York, New York, USA
    Nat Med 15:1369-76. 2009
  7. ncbi Analysis of BCL6-interacting proteins by tandem mass spectrometry
    Rodney R Miles
    Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Mol Cell Proteomics 4:1898-909. 2005
  8. ncbi A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling
    Avi Shvarts
    Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
    Genes Dev 16:681-6. 2002
  9. ncbi Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells
    Ryan T Phan
    Institute for Cancer Genetics, the Department of Pathology and Genetics and Development, Columbia University, New York, New York 10032, USA
    Nat Immunol 8:1132-9. 2007
  10. ncbi Regulation of the plasma cell transcription factor Blimp-1 gene by Bach2 and Bcl6
    Kyoko Ochiai
    Department of Biochemistry, Tohoku University Graduate School of Medicine, Seiryo machi 2 1, Sendai 980 8575, Japan
    Int Immunol 20:453-60. 2008

Research Grants

  1. GENETIC ANALYSIS OF POLARITY
    RUTH M STEWARD; Fiscal Year: 2010
  2. GENETIC ANALYSIS OF POLARITY
    Ruth Steward; Fiscal Year: 2009
  3. Development of cambinol analogues as antilymphoma agents
    Antonio Bedalov; Fiscal Year: 2010
  4. Development of cambinol analogues as antilymphoma agents
    Antonio Bedalov; Fiscal Year: 2009
  5. Molecular Targeting of Diffuse Large B-cell Lymphoma
    Ari M Melnick; Fiscal Year: 2010
  6. Regulation of plasma cell differentiation by PI3-kinase
    ROBERT RICKERT; Fiscal Year: 2007
  7. Molecular Basis of Action of the Putative Oncogene BCL-6
    Vivian J Bardwell; Fiscal Year: 2010
  8. ANTIGEN-INDUCED B LYMPHOCYTE DEVELOPMENT
    Douglas Fearon; Fiscal Year: 2006
  9. Role of BCL6 Mutation in Lymphomagenesis
    Riccardo Dalla Favera; Fiscal Year: 2007
  10. PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas
    Margaret Shipp; Fiscal Year: 2007

Scientific Experts

Detail Information

Publications182 found, 100 shown here

  1. ncbi PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells
    Fang Wei
    Department of Animal Biology and Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Mol Cell Biol 29:4612-22. 2009
    b>BCL6 is a transcriptional repressor crucial for germinal center formation. BCL6 represses transcription by a variety of mechanisms by binding to specific DNA sequences or by recruitment to DNA by protein interactions...
  2. ncbi BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells
    Huifeng Niu
    Institute for Cancer Genetics, Columbia University, 1150 St Nicholas Ave, New York, NY 10032, USA
    J Exp Med 198:211-21. 2003
    The BCL6 proto-oncogene encodes a transcriptional repressor required for the development of germinal centers (GCs) and implicated in the pathogenesis of GC-derived B cell lymphoma...
  3. ncbi Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein
    G David
    Unite de Recombinaison et Expression Genetique, INSERM U163, Institut Pasteur, Paris, France
    Oncogene 16:2549-56. 1998
    ..a krüppel-like zinc finger protein with a POZ domain shared with a subset of regulatory proteins including the BCL6 leukemogenic protein. PLZF, like BCL6, strongly represses transcription initiated from different promoters...
  4. ncbi Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas
    B W Baron
    Department of Pathology, University of Chicago, IL 60637
    Proc Natl Acad Sci U S A 90:5262-6. 1993
    ..We propose the name BCL6 (B-cell lymphoma 6) for this gene, since it is likely to play a role in the pathogenesis of certain B-cell lymphomas...
  5. ncbi Control of inflammation, cytokine expression, and germinal center formation by BCL-6
    A L Dent
    Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Science 276:589-92. 1997
    ..Thus, dysregulation of STAT-responsive genes may underlie the inflammatory disease in BCL-6-deficient mice and participate in lymphoid malignancies...
  6. ncbi A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas
    Leandro C Cerchietti
    Division of Hematology and Oncology, Weill Cornell Medical College of Cornell University, New York, New York, USA
    Nat Med 15:1369-76. 2009
    ..PU-H71 also induced cell death in primary human DLBCL specimens...
  7. ncbi Analysis of BCL6-interacting proteins by tandem mass spectrometry
    Rodney R Miles
    Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Mol Cell Proteomics 4:1898-909. 2005
    B-cell lymphoma 6 (BCL6) is a 95-kDa nuclear phosphoprotein and member of the Pox virus zinc finger/bric-a-brac, tramtrack, broad complex (POZ/BTB) family of transcription factors...
  8. ncbi A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling
    Avi Shvarts
    Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
    Genes Dev 16:681-6. 2002
    ..Using retroviral cDNA expression libraries, we identify BCL6 as a potent inhibitor of senescence...
  9. ncbi Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells
    Ryan T Phan
    Institute for Cancer Genetics, the Department of Pathology and Genetics and Development, Columbia University, New York, New York 10032, USA
    Nat Immunol 8:1132-9. 2007
    ..Because Bcl-6 is required for the maintenance of germinal centers, our findings suggest that the extent of genotoxic stress controls the fate of germinal center B cells by means of Bcl-6...
  10. ncbi Regulation of the plasma cell transcription factor Blimp-1 gene by Bach2 and Bcl6
    Kyoko Ochiai
    Department of Biochemistry, Tohoku University Graduate School of Medicine, Seiryo machi 2 1, Sendai 980 8575, Japan
    Int Immunol 20:453-60. 2008
    ..is suppressed in B cells by transcription repressors BTB and CNC homology 2 (Bach2) and B cell lymphoma 6 (Bcl6)...
  11. ncbi The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells
    Ryan T Phan
    Institute for Cancer Genetics and the Department of Pathology, Columbia University, New York, New York 10032, USA
    Nature 432:635-9. 2004
    The human proto-oncogene BCL6 encodes a BTB/POZ-zinc-finger transcriptional repressor that is necessary for germinal-centre formation and is implicated in the pathogenesis of B-cell lymphoma...
  12. ncbi The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis
    Beverly W Baron
    Department of Pathology, University of Chicago, Chicago, IL 60637, USA
    Proc Natl Acad Sci U S A 99:2860-5. 2002
    b>BCL6, a gene on chromosome 3 band q27, encodes a Kruppel-type zinc finger transcriptional repressor. Rearrangements of this gene are frequent in various kinds of lymphomas, particularly of the large-cell B-cell type...
  13. ncbi Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells
    Jose M Polo
    Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA
    Nat Med 10:1329-35. 2004
    The BTB/POZ transcriptional repressor and candidate oncogene BCL6 is frequently misregulated in B-cell lymphomas...
  14. ncbi HIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cells
    Maria Chiara Deregibus
    Cattedra di Nefrologia, Dipartimento di Medicina Interna Università di Torino, Centro Ricerca Medicina Sperimentale CeRMS, Italy
    J Biol Chem 277:25195-202. 2002
    ....
  15. ncbi MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation
    Naoyuki Fujita
    Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
    Cell 119:75-86. 2004
    ....
  16. ncbi Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene
    Farha H Vasanwala
    Department of Microbiology and Immunology and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Immunol 169:1922-9. 2002
    ..Repression of AP-1 function by BCL-6 may be a key mechanism for how BCL-6 regulates gene expression to control inflammation, lymphocyte differentiation, and lymphomagenesis...
  17. ncbi The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene
    I S Lossos
    Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, CA 94305 5151, USA
    Leukemia 17:1390-7. 2003
    The BCL6 gene, which functions as a transcription repressor, is the target of multiple chromosomal translocations in non-Hodgkin's lymphomas (NHL)...
  18. ncbi Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins
    Stefano A Pileri
    Istituto di Ematologia e Oncologia Medica, L e A Seràgnoli Unità Cliniche e di Anatomia Patologica, Universita di Bologna, Bologna, Italy
    Am J Pathol 162:243-53. 2003
    ..However, it differs from other aggressive B-cell lymphomas in that it shows defective immunoglobulin production despite the expression of OCT-2, BOB.1, and PU.1 transcription factors and the lack of IgV(H) gene crippling mutations...
  19. ncbi Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma
    Laura Pasqualucci
    Institute for Cancer Genetics and the Department of Pathology, Columbia University, New York, NY 10032, USA
    Blood 101:2914-23. 2003
    The BCL6 proto-oncogene encodes a transcriptional repressor whose expression is deregulated by chromosomal translocations in approximately 40% of diffuse large B-cell lymphomas (DLBCLs)...
  20. ncbi The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression
    P Dhordain
    U124 INSERM IRCL, Place de Verdun, F 59045 Lille Cedex, France and Howard Hughes Medical Institute and The Salk Institute for Biological Studies, La Jolla, CA 92037, USA
    Nucleic Acids Res 26:4645-51. 1998
    ..Recently, we reported that SMRT also directly associates with LAZ3(BCL-6), a POZ/Zn finger transcriptional repressor involvedin the pathogenesis of non-Hodgkin lymphomas...
  21. ncbi Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor
    H Niu
    Departments of Pathology and Genetics and Development, Columbia University, New York, New York 10032 USA
    Genes Dev 12:1953-61. 1998
    ..This signaling pathway may be crucial for the control of B-cell differentiation and antibody response and has implications for the regulation of other POZ/zinc finger transcription factors in other tissues...
  22. ncbi A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma
    Masumichi Saito
    Institute for Cancer Genetics, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA
    Cancer Cell 12:280-92. 2007
    The BCL6 proto-oncogene encodes a transcriptional repressor necessary for the development of germinal centers (GCs) and directly implicated in lymphomagenesis...
  23. ncbi Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma
    B H Ye
    Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, NY 10032
    Science 262:747-50. 1993
    ..Thus, BCL-6 may be a proto-oncogene specifically involved in the pathogenesis of DLCL...
  24. ncbi BCL-6 protein is expressed in germinal-center B cells
    G Cattoretti
    Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Blood 86:45-53. 1995
    ..Because DLCL derive from germinal-center B cells, deregulated BCL-6 expression may contribute to lymphomagenesis by preventing postgerminal center differentiation...
  25. ncbi BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor
    C C Chang
    Division of Oncology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Proc Natl Acad Sci U S A 93:6947-52. 1996
    ..of diffuse large cell lymphoma are associated with chromosomal translocations that deregulate the expression of the BCL6 gene by juxtaposing heterologous promoters to the BCL-6 coding domain...
  26. ncbi The proto-oncogene BCL-6 in normal and malignant B cell development
    Huifeng Niu
    Institute of Cancer Genetics, University of Columbia, New York, NY 10032, USA
    Hematol Oncol 20:155-66. 2002
    ..This suggests that deregulated expression of BCL-6 may contribute to lymphomagenesis...
  27. ncbi The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
    B H Ye
    Department of Pathology, Columbia University, New York, New York 10032, USA
    Nat Genet 16:161-70. 1997
    ..Altered expression of BCL-6 in lymphoma represents a deregulation of the pathway normally leading to B cell proliferation and germinal centre formation...
  28. ncbi Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein
    P Dhordain
    U124 Institut National de la Santé et de la Recherche Médicale, Institut de Recherches sur le Cancer de Lille Place de Verdun, F 59045 Lille Cedex France
    Proc Natl Acad Sci U S A 94:10762-7. 1997
    The LAZ3/BCL6 (lymphoma-associated zinc finger 3/B cell lymphomas 6) gene frequently is altered in non-Hodgkin lymphomas...
  29. ncbi BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts
    T Onizuka
    Department of Pathology, University of Tokyo, Japan
    Blood 86:28-37. 1995
    ..These results suggest that the BCL-6 protein, expressed in B cells of the germinal centers which are important in the maturation of immune responses, may play some physiological role(s) in the germinal center B cells...
  30. ncbi Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR
    Stella Maris Ranuncolo
    Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA
    Nat Immunol 8:705-14. 2007
    ..Our data demonstrate a transcriptional regulatory loop whereby Bcl-6 mediates the centroblast phenotype through transient silencing of ATR...
  31. ncbi Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes
    H M Shen
    Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, IL 60617, USA
    Science 280:1750-2. 1998
    ..Significant mutations were not observed in c-MYC, S14, or alpha-fetoprotein (AFP) genes, but BCL-6 was highly mutated in a large proportion of memory B cells of normal individuals. The mutation pattern was similar to that of Ig genes...
  32. ncbi A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells
    L Flenghi
    Institute of Internal Medicine, University of Perugia, Italy
    Am J Pathol 147:405-11. 1995
    ..These findings indicate that BCL-6 expression is specifically regulated during B lymphocyte development and suggest that BCL-6 may play a role during B cell differentiation in the germinal center...
  33. ncbi Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B
    S Deltour
    Centre National de la Recherche Scientifique Unité Mixte de Recherche 8526, Institut de Biologie de Lille, Institut Pasteur de Lille, 1 rue Calmette, 59017 Lille Cedex, France
    Proc Natl Acad Sci U S A 96:14831-6. 1999
    ..Taken together, our studies show that the recruitment onto target promoters of an HDAC complex is not a general property of transcriptional repressors containing a conserved BTB/POZ domain...
  34. ncbi Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma
    A Migliazza
    Department of Pathology, Columbia University, New York, NY 10032, USA
    Proc Natl Acad Sci U S A 92:12520-4. 1995
    The BCL6 gene encodes a zinc-finger transcription factor and is altered by chromosomal arrangements in its 5' noncoding region in approximately 30% of diffuse large-cell lymphoma (DLCL)...
  35. ncbi POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1
    Dong Kee Lee
    Department of Biochemistry and Molecular Biology, BK21 Project for Medical Sciences, Institute of Genetic Sciences, Yonsei University School of Medicine, 134 Shinchon dong, Seodaemoon ku, Seoul 120 752, Korea
    J Biol Chem 277:26761-8. 2002
    ..Our data suggest that POZ domain represses transcription by interacting with Sp1 zinc fingers and by interfering with the DNA binding activity of Sp1...
  36. ncbi Clinical relevance of CD10, BCL-6 and multiple myeloma-1 expression in diffuse large B-cell lymphomas in Malaysia
    Suat Cheng Peh
    Department of Pathology, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia
    Pathol Int 58:572-9. 2008
    ..038). No apparent difference in overall and disease-free survival was noted between patients with GCB and non-GCB disease. BCL-6 expression by tumor cells appears to be associated with poorer prognosis...
  37. ncbi Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Krüppel-like zinc-finger protein
    T Miki
    First Department of Internal Medicine, Tokyo Medical and Dental University, Japan
    Blood 83:26-32. 1994
    ..A part of the sequence was essentially identical to that of a genomic fragment, ZNF51, previously reported to be located at 3qter...
  38. ncbi Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6
    C W Wong
    Section of Microbiology, Division of Biological Sciences, University of California, Davis, California 95616, USA
    J Biol Chem 273:27695-702. 1998
    ..Our results demonstrate that otherwise similar transcription factors can differ notably in their interactions with the corepressor machinery...
  39. ncbi LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas
    J P Kerckaert
    Unite 124 INSERM, Institut de Recherches sur le Cancer de Lille, France
    Nat Genet 5:66-70. 1993
    ..The gene (LAZ3) encodes a 79 kDa protein containing six zinc-finger motifs and sharing amino-terminal homology with several ..
  40. ncbi Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3
    Ana Borovecki
    Department of Clinical Pathology and Cytology, Merkur University Hospital, Zajceva 19, 10000 Zagreb, Croatia
    Croat Med J 49:625-35. 2008
    To define prognostic significance of B-cell differentiation genes encoding proteins and BCL2 and BCL6 gene abnormalities in diffuse large B-cell lymphoma and follicular lymphoma grade 3 with >75% follicular growth pattern.
  41. ncbi Primary diffuse large B-cell lymphoma of the oral cavity: germinal center classification
    Indraneel Bhattacharyya
    Department of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL 32610, USA
    Head Neck Pathol 4:181-91. 2010
    ..B-cell like (non-GCB) lymphomas based on gene expression profiles and by immunohistochemical expression of CD10, BCL6 and MUM-1. GCB lymphomas tend to exhibit a better prognosis than non-GCB lymphomas...
  42. ncbi Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults
    Bhavana J Dave
    Human Genetics Laboratory, Munroe Meyer Institute for Genetics and Rehabilitation, 985440 Nebraska Medical Center, Omaha, NE 68198 5440, USA
    Cancer Genet Cytogenet 153:115-21. 2004
    ..Our results confirmed that the pediatric cases did not show rearrangements of 3q27 (BCL6), 14q32 (IGH), 18q21 (BCL2), 8q24 (CMYC), and 17p13 (TP53), except for one case with IGH;BCL2 dual fusion [t(14;18)(..
  43. ncbi Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials
    Heinz Wolfram Bernd
    Institute of Pathology, Universitatsklinikum Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160 D 23538 Lübeck, Germany
    Haematologica 94:1569-80. 2009
    ....
  44. ncbi Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma
    Rachel Lynn Sargent
    Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Am J Surg Pathol 32:1643-53. 2008
    ..trisomies of chromosomes 3 (15 cases), 12 (16 cases), and 18 (17 cases); rearrangements (R) of IgH (10 cases), BCL6 (6 cases), PAX5 (7 cases), and MALT1 (16 cases); and deletion 6q21 (7 cases)...
  45. ncbi Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP
    Jesse Shustik
    Division of Medical Oncology, Laboratory Medicine, BC Cancer Agency, University of British Columbia, Vancouver, Canada
    Haematologica 95:96-101. 2010
    b>BCL6 gene rearrangement is the most frequent chromosomal abnormality in diffuse large B-cell lymphoma, a malignancy characterized by genetic heterogeneity and wide variability in clinical outcome...
  46. ncbi Presence of simian virus 40 in diffuse large B-cell lymphomas in Tunisia correlates with germinal center B-cell immunophenotype, t(14;18) translocation, and P53 accumulation
    Khaled Amara
    Department of Pathology, CHU Farhat Hached, Sousse, Tunisia
    Mod Pathol 21:282-96. 2008
    ..Therefore, we evaluated by immunohistochemistry the expression patterns of CD10, BCL6, MUM1, BCL2, and P53 in 86 diffuse large B-cell lymphomas (48 simian virus 40-positive and 38 simian virus 40-..
  47. ncbi Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma
    Robin A Roberts
    Department of Pathology, University of Arizona, Tucson, AZ 85724 5043, USA
    Lab Invest 87:979-97. 2007
    ..ArrayPlate gene expression results were confirmed with immunohistochemistry for BCL2, BCL6, and HLA-DR, showing agreement between mRNA species and the proteins they encode...
  48. ncbi BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome
    Maria Grazia Tibiletti
    Department of Human Morphology, Unit of Pathology, University of Insubria Ospedale di Circolo, Varese, Italy
    Hum Pathol 40:645-52. 2009
    ..The fluorescent in situ hybridization analysis with the panel used in this study is useful to detect the heterogeneity of diffuse large B-cell lymphomas and identify alterations with prognostic implications...
  49. ncbi Primary mediastinal B-cell lymphoma: detection of BCL2 gene rearrangements by PCR analysis and FISH
    Cherie H Dunphy
    Divisions of Hematopathology, University of North Carolina, Chapel Hill, NC, USA
    J Hematop 1:77-84. 2008
    ..Of further interest, BCL6 gene mutations and BCL6 and/or MUM1 expression in a number of PMBCLs have supported an activated B-cell (ABC) ..
  50. ncbi [Molecular abnormalities in lymphomas]
    G Delsol
    Universite Paul Sabatier, CHU de Toulouse Purpan, Toulouse, France
    Bull Cancer 97:1347-64. 2010
    ..subgroups of tumors, one with gene expression signature corresponding to germinal center B-cell-like (GCB: CD10+, BCL6 [B-Cell Lymphoma 6]+, centerine+, MUM1-) and a subgroup expressing an activated B-cell-like signature (ABC: CD10-, ..
  51. ncbi Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization
    Mattias Berglund
    Department of Molecular Medicine, Karolinska Hospital, Stockholm, Sweden
    Mod Pathol 15:807-16. 2002
    ..Furthermore, immunohistochemical expression analyses of BCL2 and BCL6/LAZ3 were performed on all cases...
  52. ncbi Microarray analysis of mercury-induced changes in gene expression in human liver carcinoma (HepG2) cells: importance in immune responses
    Wellington K Ayensu
    Cellomics and Toxicogenomics Research Laboratory, NIH RCMI Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, Jackson, Mississippi 39217, USA Email
    Int J Environ Res Public Health 3:141-73. 2006
    ..region Y)-box18SRY, 21 (splicing factor, arginine/serine-rich 15 and ATP-binding), and X (including BCL6-co-repressor)...
  53. ncbi Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma
    W G McCluggage
    Department of Pathology, Royal Group of Hospitals Trust, Belfast City Hospital Trust, Belfast, UK
    Histopathology 41:414-20. 2002
    ..We correlated this with the immunohistochemical expression of CD10, bcl2 and bcl6, markers which are usually expressed by the neoplastic cells in follicular lymphomas...
  54. ncbi Derivative (3)t(3;18)(q27;q21)t(18;16)(q21;?) involving the BCL2 and BCL6 genes in follicular lymphoma with t(3;14;18)(q27;q32;q21)
    Katsuya Yamamoto
    Hematology Oncology, Department of Medicine, Kobe University Graduate School of Medicine, 7 5 1 Kusunoki cho, Chuo Ku, Kobe 650 0017, Japan
    Cancer Genet Cytogenet 179:69-75. 2007
    ..by t(14;18)(q32;q21) involving the BCL2 gene (BCL2), and is often associated with 3q27 translocations involving the BCL6 gene (BCL6). We describe here an unusual case of FL with a variant three-way translocation t(3;14;18)(q27;q32;q21)...
  55. ncbi Diffuse large B-cell lymphomas with germinal center B-cell-like differentiation immunophenotypic profile are associated with high apoptotic index, high expression of the proapoptotic proteins bax, bak and bid and low expression of the antiapoptotic protei
    Maria Bai
    Department of Pathology, Medical Faculty, University of Ioannina, Ioannina, Greece
    Mod Pathol 17:847-56. 2004
    ..Therefore, the bcl6/CD10/MUM1/CD138 differentiation immunophenotypic profiles were studied in relation to (a) the apoptotic index, (b) ..
  56. ncbi JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells
    Eggi Arguni
    Department of Developmental Genetics H2, Graduate School of Medicine, Chiba University, 1 8 1 Inohana, Chuo Ku, Chiba 260 8670, Japan
    Int Immunol 18:1079-89. 2006
    The Bcl6 proto-oncogene, which encodes a transcriptional repressor, is ubiquitously expressed and predominantly in germinal center (GC) B cells...
  57. ncbi High levels of topoisomerase IIalpha protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatment
    George Pentheroudakis
    Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece
    Leuk Lymphoma 51:1260-8. 2010
    ..expression of cell cycle proteins (Ki67, p53, HDM2, p21, p14, pRb, p16, and cyclins A, B1, D1, D2, D3, and E) and BCL6/CD10/MUM1/CD138 B-cell differentiation immunophenotype and outcome...
  58. ncbi Peripheral T-cell lymphoma with follicular T-cell markers
    Socorro Maria Rodriguez-Pinilla
    Lymphoma Group, Molecular Pathology Programme, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Am J Surg Pathol 32:1787-99. 2008
    ..The aim of this study was to establish whether other PTCL subgroups also express TFH cell markers...
  59. ncbi A role for Bcl6 in sequential class switch recombination to IgE in B cells stimulated with IL-4 and IL-21
    Daisuke Kitayama
    Department of Developmental Genetics H2, Graduate School of Medicine, Chiba University, Chiba 260 8670, Japan
    Mol Immunol 45:1337-45. 2008
    ..b>Bcl6, a sequence specific transcriptional repressor, is highly expressed in germinal center B cells and suppresses ..
  60. ncbi Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma
    Xiuyan Xie
    Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH 44195, USA
    Mod Pathol 21:653-9. 2008
    ..and 10 DLBCL-LT) were classified based on the WHO-EORTC criteria and studied for expression of CD20, BCL2, BCL6, CD10, MUM-1, and HGAL by immunohistochemistry. Results were correlated with clinical features...
  61. ncbi Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance
    Giorgio Cattoretti
    Department of Pathology, Columbia University Medical Center, New York, NY 10032, USA
    J Immunol 177:6930-9. 2006
    ..1+ B cells. IRF4, which is highly expressed in BCL6- GC B cells, is necessary for class switch recombination and the plasma cell differentiation at exit from the GC...
  62. ncbi Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas
    XiaoQing Lu
    Sylvester Comprehensive Cancer Center, Division of Hematology Oncology, Department of Medicine, University of Miami, 1475 NW 12th Ave D8 4, Miami, FL 33136, USA
    Blood 105:2924-32. 2005
    ..high expression of components of the interleukin 4 (IL-4) signaling pathway and of IL-4 target genes such as BCL6 and HGAL, whose high expression independently predicts better survival...
  63. ncbi Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival
    Yasodha Natkunam
    Department of Pathology, Stanford University School of Medicine, CA, USA
    Blood 109:298-305. 2007
    ..b>BCL6 (26%), CD10 (0%), BCL2 (31%), Blimp1 (0...
  64. ncbi A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy
    William W L Choi
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3135, USA
    Clin Cancer Res 15:5494-502. 2009
    ..Since then, new antibodies specific to germinal center B-cells have been developed, which might improve the performance of an immunostain algorithm...
  65. ncbi IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells
    Yuou Teng
    Department of Hematology, Graduate School of Medicine, Tokyo Medical and Dental University, 1 5 45 Yushima, Tokyo 113 8519, Japan
    Eur J Cell Biol 86:581-9. 2007
    ..of the plasma cell markers CD38 and CD138 and downregulation of the germinal center cell marker B-cell lymphoma 6 (BCL6) were also observed...
  66. ncbi BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells
    Himabindu Ramachandrareddy
    Department of Pathology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Proc Natl Acad Sci U S A 107:11930-5. 2010
    b>BCL6 encodes a transcriptional repressor that is essential for the germinal center (GC) reaction and important in lymphomagenesis...
  67. ncbi The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome
    Sharon L Barrans
    HMDS, Academic Unit of Haematology and Oncology, Leeds General Infirmary, Leeds, United Kingdom
    Clin Cancer Res 9:2133-9. 2003
    ..t(14;18) was most commonly associated with the subset of DLBCLs that expressed a GC phenotype, defined as CD10+, BCL6+ (GC-type DLBCL): positive in 14 of 47 (30%) cases, compared with 4 of 89 (5%) in the non-GC group (Pearson's chi(2)..
  68. ncbi AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity
    I S Lossos
    Department of Medicine, Division of Hematology Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA
    Leukemia 18:1775-9. 2004
    ..We also tested for the presence of intraclonal heterogeneity in immunoglobulin and BCL6 genes in those same tumors and in follicle center lymphomas (FCL) that transformed to DLBCL...
  69. ncbi The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas
    Yasodha Natkunam
    Department of Pathology, Stanford University School of Medicine, CA, USA, and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Blood 109:1636-42. 2007
    We previously developed a multivariate model based on the RNA expression of 6 genes (LMO2, BCL6, FN1, CCND2, SCYA3, and BCL2) that predicts survival in diffuse large B-cell lymphoma (DLBCL) patients...
  70. ncbi Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation
    Marc Seifert
    Institute of Cell Biology Cancer Research, University of Duisburg Essen, Medical School, D 45122 Essen, Germany
    J Exp Med 206:2659-69. 2009
    ..and IgM(+)IgD(-/low)CD27(+) B cell subsets carry, like class-switched memory B cells, mutations in the Bcl6 gene as a genetic trait of a GC experience...
  71. ncbi Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses
    Akiko Miyagi Maeshima
    Clinical Laboratory, National Cancer Center Hospital, Tsukiji 5 1 1, Chuo Ku, Tokyo 104 0045, Japan
    Cancer Sci 99:1760-8. 2008
    ..morphologically, immunohistochemically, and by interface fluorescence in situ hybridization (FISH: IGH/BCL2 fusion, BCL6 translocation) analysis...
  72. ncbi Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?
    Anneke G Bosga-Bouwer
    Department of Medical Genetics, University Medical Center Groningen, and University of Groningen, 9713AW Groningen, The Netherlands
    Hum Pathol 37:528-33. 2006
    ..in the WHO classification, taking into account other cytogenetical aberrations, immunohistochemistry for P53, bcl2, bcl6, and CD10, rearrangement of the proto-oncogene myc, and mutation of the tumor suppressor gene TP53...
  73. ncbi The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America
    Ellen D Remstein
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester MN 55905, USA
    Am J Surg Pathol 30:1546-53. 2006
    ..are few data regarding their frequency in different anatomic sites or the frequency of translocations involving BCL6 or kappa or lambda immunoglobulin light chain genes (IGK or IGL), particularly in patients from geographic regions ..
  74. ncbi Primary follicular lymphoma of the testis and epididymis in adults
    Chris M Bacon
    Department of Pathology, University of Cambridge, Box 231, Level 3 Lab Block, Addenbrooke s Hospital, Hills Road, Cambridge, CB2 2QQ, UK
    Am J Surg Pathol 31:1050-8. 2007
    ..The neoplastic cells expressed CD10 and Bcl-6, but not Bcl-2 and lacked t(14;18)(q32;q21)/IGH-BCL2 and BCL6 gene rearrangements. Four of the five patients were 35 years old or younger, and 4 presented with stage 1EA disease...
  75. ncbi Somatic mutations and activation-induced cytidine deaminase (AID) expression in established rheumatoid factor-producing lymphoblastoid cell line
    Yaniv Gil
    Department of Experimental Medicine and Cancer Research, Hebrew University Hadassah Medical School, Ein Karem, Jerusalem, Israel
    Mol Immunol 44:494-505. 2007
    ..The opposite is true for the germinal center-specific BCL6 gene: it is expressed in adult peripheral blood B cells and is no longer expressed in LCLs...
  76. ncbi G-rich proto-oncogenes are targeted for genomic instability in B-cell lymphomas
    Michelle L Duquette
    Department of Immunology, University of Washington School of Medicine, Seattle, Washington 98195, USA
    Cancer Res 67:2586-94. 2007
    ..Genomic instability of a subset of proto-oncogenes, including c-MYC, BCL6, RhoH, PIM1, and PAX5, can contribute to initial tumor development and has been correlated with poor prognosis and ..
  77. ncbi The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70
    G E Muscat
    University of Queensland, Centre for Molecular and Cellular Biology, Ritchie Research Laboratories, B402A, St Lucia 4072, Queensland, Australia
    Nucleic Acids Res 26:2899-907. 1998
    ..g. Rev-erbAalpha/beta), Mxi-1 and Mad bHLH-zip proteins and the oncoproteins PLZF and LAZ3/BCL6 is mediated by the corepressors N-CoR and SMRT...
  78. ncbi Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations
    Naoto Tomita
    Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
    Haematologica 94:935-43. 2009
    ..Lymphoid neoplasm with 18q21.3/BCL2 and 8q24/MYC translocation to immunoglobulin (IG) genes as dual-hit lymphoma/leukemia is very rare and known to have a poor clinical outcome...
  79. ncbi [A clinical study of chromosome translocations in extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in Chinese patients]
    Ge Hong Dong
    Department of Pathology, Health Science Center, Peking University, Beijing 100191, China
    Zhonghua Nei Ke Za Zhi 48:181-5. 2009
    ..To investigate the genetic aberrations in extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) lymphomas from different sites of the body in Chinese patients...
  80. ncbi The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD
    P Bailey
    University of Queensland, Centre for Molecular and Cellular Biology, Ritchie Research Laboratories, Brisbane, Australia
    Mol Endocrinol 13:1155-68. 1999
    ..g. Rev-erbAalpha/beta), Mad/Max bHLH (basic helix loop helix)-LZ proteins, and oncoproteins, PLZF and LAZ3/BCL6, bind DNA and silence transcription by recruiting a repressor complex that contains N-CoR (nuclear receptor ..
  81. ncbi Cytogenetic and clinicopathological characterization by fluorescence in situ hybridization on paraffin-embedded tissue sections of twenty-six cases with malignant lymphoma of small intestine
    Naohisa Yoshida
    Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan
    Scand J Gastroenterol 41:212-22. 2006
    ..The aim of this study was to determine the frequency of chromosomal translocations involving the BCL1, BCL2, c-MYC, BCL6 and MALT1 genes by using fluorescence in situ hybridization directly on paraffin-embedded tissue sections (tissue-..
  82. ncbi Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis
    Hee Jin Huh
    Department of Laboratory Medicine, Dongguk University, College of Medicine, Siksa dong, Ilsandong gu, Goyang, Gyeonggi Do, Republic of Korea
    Cancer Genet Cytogenet 186:1-5. 2008
    ..chain (IGH) dual-color break-apart rearrangement probe, an LSI p16 SpectrumOrange/CEP 9 SpectrumGreen probe, an LSI BCL6 dual-color break-apart rearrangement probe. Among 150 cases, 29 cases (19...
  83. ncbi The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function
    Xiaoyu Li
    Division of Hematology and Oncology, Cancer Biology Program, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA
    Mol Cell Biol 22:1158-71. 2002
    ..RhoH is encoded by a hematopoiesis-specific Rho-related gene recently identified in a fusion transcript with bcl6 in lymphoma cell lines...
  84. ncbi Dominant negative retinoic acid receptor initiates tumor formation in mice
    Tara S Kupumbati
    Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
    Mol Cancer 5:12. 2006
    ..This begs the question of whether chronic physiological RAR activation by endogenous retinoids is likewise anti-tumorigenic...
  85. ncbi Differential regulation of germinal center genes, BCL6 and SWAP-70, during the course of MAIDS
    C F Qi
    Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 0760, USA
    Mol Immunol 36:1043-53. 1999
    ..Normal GC formation is critically dependent on a number of genes including the transcription factor, Bcl6. Deregulated expression of BCL6 protein has been implicated in the development of human and mouse B cell lymphomas...
  86. ncbi Micronodular T-cell/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis
    Ahmet Dogan
    Department of Histopathology, University College London, London, UK
    Am J Surg Pathol 27:903-11. 2003
    ..histology were reviewed and immunohistochemistry was performed for immunoglobulins, CD20, CD79a, CD3, CD68, CD10, BCL6, BCL2, OCT-2, epithelial membrane antigen, CD30, CD138, and EBV markers...
  87. ncbi EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts
    Jing Fang
    Program in Stem and Progenitor Cell Biology, Maine Medical Center Research Institute, Scarborough, ME 04074, USA
    Blood 110:2361-70. 2007
    ..In contrast, inhibitory cyclin G2, p27/Cdkn1b, and B-cell leukemia/lymphoma 6 (Bcl6) were sharply down-modulated...
  88. ncbi BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia
    Yukiya Yamamoto
    Department of Hematology, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan
    Blood 116:4274-83. 2010
    ..BCOR is a transcriptional corepressor through the proto-oncoprotein, BCL6, recruiting histone deacetylases and polycomb repressive complex 1 components...
  89. ncbi [Febrile cellulitis surrounding a scar revealing a large immunoblastic B-cell lymphoma]
    M Charavin-Cocuzza
    Pôle Pluridisciplinaire de Médecine, Service de Dermatologie, CHU Albert Michallon, BP 217, 38043 Grenoble Cedex 09, France
    Ann Dermatol Venereol 135:848-51. 2008
    ..We report the first case of a pericicatricial skin infiltration, mimicking febrile dermohypodermitis, revealing diffuse immunoblastic large B-cell non-Hodgkin's lymphoma...
  90. ncbi BCoR-L1 variation and breast cancer
    Felicity Lose
    Cancer and Cell Biology Division, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland, Australia, 4006
    Breast Cancer Res 9:R54. 2007
    ..b>BCL6 corepressor-like 1 (BCoR-L1) is a newly described BRCA1-interacting protein that displays high homology to several ..
  91. ncbi Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas
    M Bai
    Department of Pathology, Medical Faculty, University of Ioannina, Ioannina, Greece
    Mod Pathol 16:471-80. 2003
    There is increasing evidence that bcl6 and CD10 expression may be related to apoptosis and cell cycle progression...
  92. ncbi Bcl6 is required for the IL-4-mediated rescue of the B cells from apoptosis induced by IL-21
    Nobuhide Tsuruoka
    Department of Developmental Genetics, Graduate School of Medicine, Chiba University, Chiba, Japan
    Immunol Lett 110:145-51. 2007
    IL-21 has a pro-apoptotic effect on freshly isolated B cells stimulated with LPS, and also induces Bcl6 expression in the activated B cells. However, a role for Bcl6 in the activated B cells is not known...
  93. ncbi Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers
    Syong H Nam-Cha
    Department of Pathology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain
    Mod Pathol 22:1006-15. 2009
    ..Markers were selected focusing on B-cell lineage and transcription program (OCT.1, OCT.2, BOB.1, BCL6, PAX-5, GCET1, KLHL6, and BLIMP1), the NF-kappaB signaling pathway (REL-B, C-REL, TRAF-1, p-50, and MUM-1) and the ..
  94. ncbi New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma
    H Adams
    Institute of Pathology, University Hospital of Basel, Basel, Switzerland
    J Clin Pathol 62:986-97. 2009
    ..Here, the clinical value of time-dependent ROC curve analysis for improving the identification of high-risk patients with colon cancers and diffuse large B-cell lymphomas (DLBCL) is explored...
  95. ncbi Repression of BCL-6 is required for the formation of human memory B cells in vitro
    Tracy C Kuo
    Department of Microbiology, Columbia University Medical Center, New York, NY 10032, USA
    J Exp Med 204:819-30. 2007
    ..These studies establish new molecular criteria for defining the memory B cell stage in human B cells...
  96. ncbi Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers
    Salah Eddine Bentebibel
    Baylor Institute for Immunology Research, Baylor Research Institute, Dallas, TX 75204, USA
    Proc Natl Acad Sci U S A 108:E488-97. 2011
    ..Tfh cells abundantly express the transcription repressor B-cell lymphoma 6 (Bcl6), a factor that is necessary and sufficient for their development in vivo...
  97. ncbi Lymph node-based disease and HHV-8/KSHV infection in HIV seronegative patients: report of three new cases of a heterogeneous group of diseases
    Antonio D'Antonio
    Unit of Pathologic Anatomy and Oncology, AO San Giovanni di Dio e Ruggi d Aragona, Via S Leonardo, Salerno, Italy
    Int J Hematol 93:795-801. 2011
    ..a distinctive and heterogeneous group of diseases with variable clinico-pathologic findings and immunophenotypes (BCL6-/MUM1+/CD138- and BCL6+/MUM1+/CD138- or BCL6-/MUM1+/CD138+)...
  98. ncbi Functional interaction of HTLV-1 tax protein with the POZ domain of the transcriptional repressor BCL6
    J Dean
    UCD Centre for Research in Infectious Diseases, School of Medicine and Medical Science, University College Dublin, Dublin, Ireland
    Oncogene 28:3723-34. 2009
    ..Using the yeast two-hybrid system to screen a human leukocyte cDNA library, we identified BCL6 (B-cell lymphoma 6) as a cellular protein, which interacts with Tax 1...
  99. ncbi BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH/BCL2
    Wiebke Gollub
    Department of Pathology, University Clinic Schleswig Holstein, Campus Luebeck, Ratzeburger Allee 160, D 23538 Luebeck, Germany
    Anticancer Res 29:4649-55. 2009
    ..A subset of cases harbours translocations involving the BCL6-gene locus...
  100. ncbi BCL6 canalizes Notch-dependent transcription, excluding Mastermind-like1 from selected target genes during left-right patterning
    Daisuke Sakano
    Department of Biomedical Sciences, Florida State University, College of Medicine, Tallahassee, FL 32306, USA
    Dev Cell 18:450-62. 2010
    ..Here, we report that B cell leukemia/lymphoma 6 (BCL6), a transcriptional repressor, is a Notch-associated factor...
  101. ncbi Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
    German Ott
    Institute of Pathology, University of Wurzburg, Wurzburg, Germany
    Blood 116:4916-25. 2010
    ..The expression of immunohistochemical markers CD5, CD10, BCL2, BCL6, human leukocyte antigen (HLA)-DR, interferon regulatory factor-4/multiple myeloma-1 (IRF4/MUM1), and Ki-67 was ..

Research Grants67

  1. GENETIC ANALYSIS OF POLARITY
    RUTH M STEWARD; Fiscal Year: 2010
    ..PDCD2 appears to be involved in human blood malignancies. This conclusion is based on its regulation by the BCL6 (B-cell lymphoma 6) oncogene and its chromosomal localization to a region of chromosome 6q27, frequently deleted in ..
  2. GENETIC ANALYSIS OF POLARITY
    Ruth Steward; Fiscal Year: 2009
    ..PDCD2 appears to be involved in human blood malignancies. This conclusion is based on its regulation by the BCL6 (B-cell lymphoma 6) oncogene and its chromosomal localization to a region of chromosome 6q27, frequently deleted in ..
  3. Development of cambinol analogues as antilymphoma agents
    Antonio Bedalov; Fiscal Year: 2010
    ..to stress and in tumorigenesis through deacetylation of important regulatory proteins including p53 and the BCL6 oncoprotein...
  4. Development of cambinol analogues as antilymphoma agents
    Antonio Bedalov; Fiscal Year: 2009
    ..to stress and in tumorigenesis through deacetylation of important regulatory proteins including p53 and the BCL6 oncoprotein...
  5. Molecular Targeting of Diffuse Large B-cell Lymphoma
    Ari M Melnick; Fiscal Year: 2010
    b>BCL6 is the most commonly involved oncogene in B-cell lymphomas, and is expressed constitutively in a majority of patients with two most frequent forms of lymphoma: the diffuse large B-cell lymphomas (DLBCL) and follicular lymphoma (FL)...
  6. Regulation of plasma cell differentiation by PI3-kinase
    ROBERT RICKERT; Fiscal Year: 2007
    ..been given to the genes involved in specifying plasma cell development (BLIMP1) and germinal center development (BCL6 and AID, activation induced cytidine deaminase)...
  7. Molecular Basis of Action of the Putative Oncogene BCL-6
    Vivian J Bardwell; Fiscal Year: 2010
    The proto-oncogene BCL6 encodes a POZ/BTB-zinc finger transcriptional repressor that is essential for normal lymphocyte development. When BCL6 is aberrantly expressed it leads to the development of diffuse large B cell lymphomas (DLBCL)...
  8. ANTIGEN-INDUCED B LYMPHOCYTE DEVELOPMENT
    Douglas Fearon; Fiscal Year: 2006
    ..The target transgenes are SHP-1, dominant negative (DN) gamma-c, and wild-type and DN BCL6, all linked via an IRES to EGFP to permit visualization of transgene expression...
  9. Role of BCL6 Mutation in Lymphomagenesis
    Riccardo Dalla Favera; Fiscal Year: 2007
    The Bcl6 gene encodes a zinc-finger transcription factor and is altered by chromosomal rearrangements in its 5' non-coding region in approximately 30% of diffuse large-cell lymphoma (DLCL)...
  10. PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas
    Margaret Shipp; Fiscal Year: 2007
    ..Rajewsky, Project 2); 3) deregulated expression of the essential GC transcription factor, BCL6, promotes the development of certain large B-cell lymphomas (R...
  11. Immunoglobulin Somatic Mutation
    Ursula Storb; Fiscal Year: 2007
    ..Surprisingly, the BCL6 proto-oncogene is highly mutated in human memory B cells. This is likely to be involved in tumorigenesis...
  12. Transcriptional silencing by the BCL6 oncoprotein
    Ari M Melnick; Fiscal Year: 2010
    b>BCL6 is the most commonly involved oncogene in diffuse large B-cell lymphomas (DLBCL)...
  13. Regulatory Modules in Normal and Transformed B-Cells
    Andrea Califano; Fiscal Year: 2009
    ..tumor B cells. In particular, we propose to investigate the subnetworks that involve two proto-oncogenes: BCL6 (a gene playing an important role in the coordination of the genetic programs leading to the GC reaction) and c-MYC ..
  14. Regulatory Modules in Normal and Transformed B-Cells
    Andrea Califano; Fiscal Year: 2007
    ..tumor B cells. In particular, we propose to investigate the subnetworks that involve two proto-oncogenes: BCL6 (a gene playing an important role in the coordination of the genetic programs leading to the GC reaction) and c-MYC ..
  15. Immunoglobulin Somatic Mutation
    Ursula Storb; Fiscal Year: 2003
    ..Surprisingly, the BCL6 proto-oncogene is highly mutated in human memory B cells. This is likely to be involved in tumorigenesis...
  16. Immunoglobulin Somatic Mutation
    Ursula Storb; Fiscal Year: 2006
    ..Surprisingly, the BCL6 proto-oncogene is highly mutated in human memory B cells. This is likely to be involved in tumorigenesis...
  17. Significance and Function of HGAL in Lymphoma
    Izidore Lossos; Fiscal Year: 2007
    ..However, our additional interesting finding is that BCL6 and FN1- both of which are IL-4 inducible genes are also independent predictors of DLBCL patients' survival...
  18. Role of POZ-zinc finger proteins in tumorigenesis.
    Pier Paolo Pandolfi; Fiscal Year: 2010
    ..As an example BCL6 and PLZF are critical players in the pathogenesis of Non- Hodgkin's lymphoma and Acute Promyelocytic Leukemia, ..
  19. Role of POZ-zinc finger proteins in tumorigenesis.
    Pier Paolo Pandolfi; Fiscal Year: 2011
    ..As an example BCL6 and PLZF are critical players in the pathogenesis of Non- Hodgkin's lymphoma and Acute Promyelocytic Leukemia, ..
  20. CHARACTERIZATION OF COREPRESSOR N-COR COMPLEXES
    Jiemin Wong; Fiscal Year: 2005
    ..factors in mediating repression by unliganded TR and RAR and by many other transcription factors including Mad/Max, BCL6/LAZ3 and ETO...
  21. Epigenetic Targeting in Non-Hodgkin's Lymphoma
    Huidong Shi; Fiscal Year: 2007
    ..these aims: 1) Discover epigenetic target genes associated with known oncogenic transcription factors c-Myc and BCL6: 2) Validate the identified epigenetic targets and investigate the regulatory role of the associated oncogenic ..